Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma

por Xun, Ziyu, Wang, Yanyu, Long, Junyu, Li, Yiran, Yang, Xu, Sun, Huishan, Zhao, Haitao
Publicado 2023

Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma

por Sun, Huishan, Long, Junyu, Zuo, Bangyou, Li, Yiran, Song, Yu, Yu, Minghang, Xun, Ziyu, Wang, Yanyu, Wang, Xi, Sang, Xinting, Zhao, Haitao
Publicado 2023

Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma

por Liao, Wanying, Long, Junyu, Li, Yiran, Xie, Fucun, Xun, Ziyu, Wang, Yanyu, Yang, Xu, Wang, Yunchao, Zhou, Kang, Sang, Xinting, Zhao, Haitao
Publicado 2022

Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma

por Zuo, Bangyou, Kuai, Jing, Long, Junyu, Bian, Jin, Yang, Xu, Yang, Xiaobo, Xun, Ziyu, Li, Yiran, Sun, Huishan, Sang, Xinting, Zhao, Haitao
Publicado 2022

Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer

por Huang, Bowen, Liu, Jianzhou, Lu, Jun, Gao, Wenyan, Zhou, Li, Tian, Feng, Wang, Yizhi, Luo, Mingjie, Liu, Dong, Xie, Congyong, Xun, Ziyu, Liu, Chengxi, Wang, Yu, Ma, Haibo, Guo, Junchao
Publicado 2022

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study

por Wang, Dongxu, Yang, Xu, Long, Junyu, Lin, Jianzhen, Mao, Jinzhu, Xie, Fucun, Wang, Yunchao, Wang, Yanyu, Xun, Ziyu, Bai, Yi, Yang, Xiaobo, Guan, Mei, Pan, Jie, Seery, Samuel, Sang, Xinting, Zhao, Haitao
Publicado 2021

Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a m...

por Zhu, Chengpei, Li, Hu, Yang, Xiaobo, Wang, Shanshan, Wang, Yunchao, Zhang, Nan, Wang, Yanyu, Xue, Jingnan, Zhang, Longhao, Ning, Cong, Yang, Xu, Xun, Ziyu, Chao, Jiashuo, Long, Junyu, Sang, Xinting, Zhu, Zhenyu, Zhao, Haitao
Publicado 2023

Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers

por Mao, Jinzhu, Wang, Dongxu, Long, Junyu, Yang, Xu, Lin, Jianzhen, Song, Yiwei, Xie, Fucun, Xun, Ziyu, Wang, Yanyu, Wang, Yunchao, Li, Yiran, Sun, Huishan, Xue, Jingnan, Song, Yang, Zuo, Bangyou, Zhang, Junwei, Bian, Jin, Zhang, Ting, Yang, Xiaobo, Zhang, Lei, Sang, Xinting, Zhao, Haitao
Publicado 2021

Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma

por Xie, Fucun, Chen, Bowen, Yang, Xu, Wang, Huaiyuan, Zhang, Ge, Wang, Yanyu, Wang, Yunchao, Zhang, Nan, Xue, Jingnan, Long, Junyu, Li, Yiran, Sun, Huishan, Xun, Ziyu, Liu, Kai, Chen, Xiangqi, Song, Yang, Yang, Xiaobo, Lu, Zhenhui, Mao, Yilei, Sang, Xinting, Lu, Yinying, Zhao, Haitao
Publicado 2022

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

por Yang, Xu, Chen, Bowen, Wang, Yanyu, Wang, Yunchao, Long, Junyu, Zhang, Nan, Xue, Jingnan, Xun, Ziyu, Zhang, Linzhi, Cheng, Jiamin, Lei, Jin, Sun, Huishan, Li, Yiran, Lin, Jianzhen, Xie, Fucun, Wang, Dongxu, Pan, Jie, Hu, Ke, Guan, Mei, Huo, Li, Shi, Jie, Yu, Lingxiang, Zhou, Lin, Zhou, Jinxue, Lu, Zhenhui, Yang, Xiaobo, Mao, Yilei, Sang, Xinting, Lu, Yinying, Zhao, Haitao
Publicado 2023